Epigenomics Nearly Quadruples Sales in Q3 | GenomeWeb

NEW YORK (GenomeWeb News) – Epigenomics yesterday reported that its third-quarter revenues bolted up over 250 percent and its net loss declined around 10 percent year over year.

The German molecular diagnostics firm reported total revenues of €1.2 million (US$1.8 million) over the three-month period ended Sept. 30, up from €320,000 for the third quarter of 2008.

Epigenomics' net loss for the third quarter fell to €2.3 million from €2.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.